Magsoothium Cbd Body

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the relief of minor aches and pains. It is a homeopathic pain reliever formulated with magnesium and arnica.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children over the age of 2 years are advised to apply the product generously to the affected area, using gentle rubbing, 2 to 3 times daily or as needed. For children under the age of 2 years, it is recommended to consult a physician prior to use.

The product is intended for topical application only. Care should be taken to ensure that the application is performed gently to avoid irritation of the skin.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

For external use only, this product must be utilized strictly as directed. It is imperative that the area being treated is not bandaged or covered, and the application of ice or heating pads in conjunction with this product is contraindicated. The use of this product with any medical device or other devices is prohibited, as is the combination with any other topical treatments.

Healthcare professionals should advise patients to avoid contact with the eyes and mucous membranes, and to refrain from applying the product to wounds or damaged skin. Pregnant or breastfeeding individuals should consult a healthcare professional prior to use.

General precautions include keeping the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

No laboratory tests are specified for monitoring during the use of this product.

Side Effects

Patients using this product should be aware of several important warnings and precautions. This product is intended for external use only and should be applied strictly as directed. It is crucial not to bandage or cover the area being treated, nor should ice or heating pads be used in conjunction with this product.

Additionally, patients are advised against using this product with any medical device or other topical treatments, as such combinations may lead to adverse effects. Care should be taken to avoid contact with the eyes or mucous membranes, and the product should not be applied to wounds or damaged skin.

For pregnant or breastfeeding individuals, it is recommended to consult a health professional prior to use to ensure safety for both the patient and the child. Adhering to these guidelines is essential to minimize the risk of adverse reactions.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Magsoothium Cbd Body (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be kept out of reach of children. In the event of accidental ingestion, medical assistance should be sought immediately, or contact a Poison Control Center.

For dosing, the product is indicated for use in adults and children over the age of 2 years. The recommended application is to apply generously with gentle rubbing to the affected area 2-3 times daily or as needed. For children less than 2 years of age, consultation with a doctor is advised prior to use.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the lack of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Monitoring of vital signs and laboratory parameters may be warranted to assess the patient's condition and guide further management.

Healthcare professionals should remain vigilant for potential symptoms that could indicate an overdosage scenario, although specific symptoms have not been detailed. If any adverse reactions or unexpected clinical presentations occur, appropriate medical intervention should be sought immediately.

For further guidance, healthcare providers are encouraged to consult local poison control centers or relevant medical authorities to obtain the most current recommendations for managing suspected overdosage cases.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of accidental ingestion, patients should be instructed to seek medical help or contact a Poison Control Center immediately. It is essential for patients to understand the importance of these precautions to ensure their safety and the safety of others.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The medication is administered topically, with a recommended application of a generous amount to the affected area, accompanied by gentle rubbing, 2-3 times daily or as needed. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Magsoothium Cbd Body, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)